164 related articles for article (PubMed ID: 16121917)
1. [Clinical study of TS-1 for inoperative and recurrent gastric cancer and evaluation of long survival cases].
Tanabe K; Yoshida K; Hamai Y; Ukon K; Ohta K; Hihara J; Toge T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1145-8. PubMed ID: 16121917
[TBL] [Abstract][Full Text] [Related]
2. [Results of treatment of far advanced and recurrent stomach cancer with TS-1].
Johira H; Yunoki S; Kawata N; Watanabe N; Hachisuka Y; Kimura M; Uomoto M; Hatano H; Sanada E; Watanabe R; Ohmori K; Miyata N
Gan To Kagaku Ryoho; 2005 Feb; 32(2):195-9. PubMed ID: 15751632
[TBL] [Abstract][Full Text] [Related]
3. [A clinical results of TS-1 in advanced and recurrent gastric cancer in our hospital].
Abe S; Kojima M; Tamura H; Kurihara H; Kitago M; Kobayashi T; Nakamura T; Ogihara T
Gan To Kagaku Ryoho; 2003 Jul; 30(7):963-70. PubMed ID: 12894711
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of TS-1 therapy for inoperable and recurrent gastric cancer].
Moriwaki T; Hyodo I; Nishina T; Kajiwara T; Tsuzuki T; Hirao K; Nakauchi M; Nasu J; Hirasaki S; Endo H; Masumoto T; Tanimizu M; Kubo Y; Kurita A
Gan To Kagaku Ryoho; 2003 Apr; 30(4):489-94. PubMed ID: 12722679
[TBL] [Abstract][Full Text] [Related]
5. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
[TBL] [Abstract][Full Text] [Related]
6. [The clinical effect of TS-1 in advanced and recurrent gastric cancer with peritoneal dissemination].
Inaba Y; Watabe S; Ohe S; Kamio Y; Koyama M; Hayashi K; Chiba M
Gan To Kagaku Ryoho; 2002 Feb; 29(2):239-44. PubMed ID: 11865630
[TBL] [Abstract][Full Text] [Related]
7. Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination.
Osugi H; Takada N; Takemura M; Kaseno S; Lee S; Ueno M; Tanaka Y; Fukuhara K; Fujiwara Y; Kinoshita H
Oncol Rep; 2002; 9(4):811-5. PubMed ID: 12066214
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of novel oral fluoropyrimidine anticancer drug, TS-1 for advanced and recurrent gastric cancer patients].
Arai K; Iwasaki Y; Kimura Y; Takahashi K; Yamaguchi T; Honma S; Takahashi T
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1297-301. PubMed ID: 14518409
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of individual TS-1 therapy for inoperable gastric cancer].
Kubo S; Misawa T; Yoshida K; Nasu T; Ihara Y; Chinen T; Harada N; Nawada H
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1161-5. PubMed ID: 12145996
[TBL] [Abstract][Full Text] [Related]
10. [Examination of the feasibility of TS-1 for postoperative advance stomach cancer patients].
Hara A; Tokuhara T; Takahashi Y; Izumi N; Iwamoto S; Satake K
Gan To Kagaku Ryoho; 2004 Apr; 31(4):601-4. PubMed ID: 15114708
[TBL] [Abstract][Full Text] [Related]
11. Feasibility study of S-1 for resectable gastric cancer with peritoneal seeding.
Fujitani K; Tsujinaka T; Hirao M
Hepatogastroenterology; 2003; 50(51):889-92. PubMed ID: 12828112
[TBL] [Abstract][Full Text] [Related]
12. [A case of recurrent gastric cancer with peritoneal dissemination successfully treated with DJ stents against bilateral hydronephrosis and chemotherapy].
Ebisui C; Souma I; Hayashi N; Fukuchi N; Izawa H; Yoshida T; Sakita I; Hasuike Y; Fujimoto T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1861-3. PubMed ID: 15553740
[TBL] [Abstract][Full Text] [Related]
13. [Two cases of gastric cancer with peritoneal dissemination that responded to TS-1 without progression or recurrence for over 3 years].
Tamura S; Miki H; Kittaka N; Nakata K; Kim C; Takiuchi D; Okada K; Okamura S; Aihara T; Sugimoto K; Ohzato H; Tomita N; Takatsuka Y
Gan To Kagaku Ryoho; 2006 Feb; 33(2):243-6. PubMed ID: 16484865
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of S-1 for advanced gastric cancer after reduction surgery].
Inaba Y; Hayashi K; Miura T; Moriya T; Takiguchi M; Isobe H; Watabe S
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1053-7. PubMed ID: 17637541
[TBL] [Abstract][Full Text] [Related]
15. [A new therapeutic approach to advanced and recurrent gastric cancer by TS-1].
Yoshida K; Nishimoto N; Kagawa Y; Hihara J; Inoue H; Kim R; Hirai T; Nishiyama M; Toge T
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1403-12. PubMed ID: 11681248
[TBL] [Abstract][Full Text] [Related]
16. [A new regimen for TS-1 therapy designed to minimize adverse reactions by introducing a one-week interval after each two-week dosing session].
Kimura Y; Kikkawa N; Iijima S; Kato T; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1403-9. PubMed ID: 12214468
[TBL] [Abstract][Full Text] [Related]
17. [Complete response in a case of recurrent gastric cancer treated with TS-1].
Yano T; Ono H; Watanabe Y; Sato M
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1461-4. PubMed ID: 12214478
[TBL] [Abstract][Full Text] [Related]
18. [Two cases of stage IV type 4 gastric cancer with good response to TS-1].
Shibata N; Watari J; Satoh T; Tanabe H; Fujiya M; Yasuda A; Saitoh Y; Yokota K; Kohgo Y; Kino Y; Matsuda M; Kasai S
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1455-9. PubMed ID: 12214477
[TBL] [Abstract][Full Text] [Related]
19. [A case of recurrent early gastric cancer with peritonitis carcinomatosa successfully treated with TS-1].
Hatanaka F; Matsuo S; Aratake Y; Uchimura K; Yokota M; Sumii T; Iguchi H; Funakoshi A
Gan To Kagaku Ryoho; 2003 May; 30(5):703-6. PubMed ID: 12795106
[TBL] [Abstract][Full Text] [Related]
20. [Safety and efficacy of chemotherapy using TS-1 followed by paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
Ohashi M; Kanda T; Yajima K; Banba T; Tanabe T; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1640-2. PubMed ID: 16315894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
